EGFR and EGFRvIII expression in primary breast cancer and cell lines

Breast Cancer Research and Treatment
James M RaeMarc E Lippman

Abstract

EGFRvIII is a constitutively activated truncated variant of the epidermal growth factor receptor (EGFR) which has been shown to increase tumorgenicity. There are conflicting reports on the extent of EGFRvIII expression in tissues which may in part stem from the use of different assay methodologies. We investigated the expression of both EGFRvIII and wild-type EGFR (EGFRwt) in cell lines and primary breast cancers. First, we used a RT-PCR assay that can simultaneously measure EGFRwt and EGFRvIII mRNA to screen 55 tumor cell lines. We show that except for EGFRvIII transfected cells, only EGFRwt was detected. We then validated a real-time PCR assay and used this to screen 170 formalin fixed paraffin-embedded primary breast cancers for evidence of EGFRwt and EGFRvIII expression. No samples were positive for EGFRvIII expression except for control transfectants and glioblastomas. In contrast, EGFRwt was expressed at varying levels in the majority of samples tested. We conclude that the expression of EGFRvIII is extremely rare in breast cancer and therefore it does not contribute to the malignant phenotype.

References

Apr 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·A J WongB Vogelstein
May 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·A J EkstrandV P Collins
Oct 24, 2001·Current Opinion in Oncology·E S KimR S Herbst
Jan 8, 2003·Proceedings of the National Academy of Sciences of the United States of America·Achim A JungbluthWebster K Cavanee
Mar 18, 2003·International Journal of Cancer. Journal International Du Cancer·Xunyi LuoCareen K Tang

❮ Previous
Next ❯

Citations

Aug 11, 2007·World Journal of Urology·G J VillaresMenashe Bar-Eli
Jul 1, 2008·Breast Cancer Research and Treatment·Christine M CoticchiaMichael D Johnson
Sep 2, 2006·Journal of Mammary Gland Biology and Neoplasia·Samuel K ChanWilliam J Gullick
Jul 26, 2006·Journal of Mammary Gland Biology and Neoplasia·Colleen SweeneyKermit L Carraway
Sep 11, 2013·ACS Nano·Chun-Hsien WuKonstantin V Sokolov
May 29, 2007·Oncogene·I Zafir-LavieY Reiter
Jul 5, 2008·Expert Review of Molecular Diagnostics·Fernanda MilaneziFernando C Schmitt
Jun 2, 2006·The Journal of Pathology·J S Reis-FilhoF C Schmitt
Sep 8, 2011·Cancer Science·Po-Sheng YangChin-Wen Chi
Sep 8, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Henriqueta A C SilvaFernando J Regateiro
Dec 3, 2014·Advances in Biological Regulation·James A McCubreyLinda S Steelman
Mar 29, 2014·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Yun-Jeong JeongYoung-Chae Chang
Oct 2, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Yago NietoSamia Nawaz
Nov 8, 2005·International Journal of Surgical Pathology·V BossuytF A Tavassoli
May 1, 2019·Expert Opinion on Biological Therapy·Caroline M Hull, John Maher
Oct 31, 2013·The International Journal of Biological Markers·Takashi EguchiHiroshi Itoh
Feb 25, 2020·Journal of Oncology·Adrianna RutkowskaPiotr Rieske
Mar 23, 2018·Acta Biochimica Et Biophysica Sinica·Ruling ShenJian Fei
Oct 31, 2013·The International Journal of Biological Markers·Priscila O CarvalhoSuely K N Marie
Aug 11, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kelly N BlehmMenashe Bar-Eli
May 31, 2013·Cancer Research·Manuel TardáguilaSantos Mañes
Aug 17, 2020·Cancer Letters·Yuetao XieFang Chen
Oct 7, 2020·Advances in Biological Regulation·Linda S SteelmanJames A McCubrey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.